Project Details
Grant Program
Faculty Development Competitive Research Grant Program 2019-2021
Project Description
Our goal is to determine whether the Crizotinib and iCRT3 combination enhances the anti-cancer effects of either Crizotinib or iCRT3 alone in human CRPC cells by targeting cancer stem-like cells and to define the mechanism by which combinatorial drugs inhibited nuclear MET/β-Catenin/ AR and novel signaling in human CRPC cells.
Short title | Targeting prostate cancer stem cell |
---|---|
Acronym | Prostate cancer drug target |
Status | Active |
Effective start/end date | 1/31/19 → 12/31/21 |
Keywords
- Prostate cancer
- Experimental therapy
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.